P. O. M. Mulder - Concepedia

Author

P. O. M. Mulder

University of Groningen

Also Known As

P Mulder, P O Mulder, P. Mulder, P. O. M. Mulder, P.O.M. Mulder, POM Mulder

Publications

283

Citations

H-Index

Concepts

All Affiliations

University of Groningen University Medical Center Groningen

About

P. O. M. Mulder is an author at University of Groningen specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	168
2	Nephrology	2	2	90
3	Critical Care Medicine	1	1	63
4	Immunology	1	1	27
5	Pathology	1	1	27

P. O. M. Mulder

Publications

253

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH) Tjip S. van der Werf, P. O. M. Mulder, Jan G. Zijlstra, Intensive Care Medicine Critical Care ManagementCritical Care MedicineIll PatientsContinuous Veno-venous HemofiltrationKidney Failure	1997	63
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteralVersus partial parenteral plus enteral nutrition P. O. M. Mulder, J. Bouman, Jourik A. Gietema, Cancer	1989	58
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes H. de Graaf, P.H.B. Willemse, Elisabeth G.E. de Vries, European Journal of Cancer Surgical OncologyOncologyPrimary TreatmentBreast OncologyMalignant Blood Disorder	1994	32
<i>In vitro</i> and <i>in vivo</i> modulation of multi‐drug resistance with amiodarone Winette T.A. van der Graaf, Elisabeth G.E. de Vries, Donald R. A. Uges, International Journal of Cancer	1991	27
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer N. H. Mulder, Dirk Th. Sleijfer, P.H.B. Willemse, European Journal of Cancer Breast OncologyOncologyBreast CancerSurgeryMetronomic Chemotherapy	1993	27
Contrasting response to cyclosporin in refractory nephrotic syndrome. Robert Zietse, Wenting Gj, P Kramer, PubMed Glomerular DiseaseRefractory Nephrotic SyndromeRenal PathologyImmunologyRenal Inflammation	1989	27
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days P. O. M. Mulder, Elisabeth G.E. de Vries, DRA Uges, British Journal of Cancer Therapeutic Drug MonitoringMedicinePharmacotherapyPharmacologyRadiation Oncology	1990	19

Page 1